New findings of heparanase in human diseases

Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5999-6004. doi: 10.26355/eurrev_201907_18347.

Abstract

Objective: This mini-review aims to discuss research works about heparanase published in 2017 and 2018 and provide a direction for therapy methods targeting heparanase.

Patients and methods: The relevant data were searched by using keywords "heparanase", "function", "diseases" and "inhibitors" in "PubMed, "Web of Science" and "China Knowledge Resource Integrated databases (CNKI)", and a hand-search was done to acquire peer-reviewed articles and reports about heparanase.

Results: Except for tumor progression, pathological processes including procoagulant activities, preeclamptic placentas, inflammation and so on are all verified to be associated with heparanase activity. Also, these newly-found functions are closely connected to certain cellular activities, including epithelial to mesenchymal transition (EMT).

Conclusions: It could be concluded that heparanase would be a potential and valuable therapeutic target.

Publication types

  • Review

MeSH terms

  • Disease*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Epithelial-Mesenchymal Transition / drug effects
  • Glucuronidase / antagonists & inhibitors*
  • Glucuronidase / metabolism
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Inflammation / pathology
  • Kidney Diseases / drug therapy
  • Kidney Diseases / metabolism
  • Kidney Diseases / pathology
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / pathology
  • Neoplasms / drug therapy
  • Neoplasms / enzymology
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Nervous System Diseases / drug therapy
  • Nervous System Diseases / metabolism
  • Nervous System Diseases / pathology
  • Virus Diseases / drug therapy
  • Virus Diseases / metabolism
  • Virus Diseases / pathology

Substances

  • Enzyme Inhibitors
  • heparanase
  • Glucuronidase